ElevateBio

Powering the creation of cell & gene therapies at a speed the world deserves.

Elevated Insights

From gene editing to biomanufacturing, learn more about the cell and gene therapy industry from our team of industry-leading experts

// Feb 2026

From Innovation to Impact: Building on Pittsburgh’s Legacy to Industrialize Advanced Therapies

Katie Shannon, VP, Site Head, BaseCamp Pittsburgh

View Insight

// Feb 2026

Why FDA Complete Response Letters Involve Manufacturing Issues – and What Must Change in Cell Therapy

By Cindy Riggins, Head of CMC Regulatory Affairs, ElevateBio

View Insight

// Feb 2026

10 Questions to Ask When Choosing a Cell Therapy CDMO

Mike Paglia, Chief Technology Officer

View Insight

// Nov 2025

Scaling Cell and Gene Therapies: Crossing the Inflection Point

By Mike Paglia, Chief Technology Officer, ElevateBio

View Insight

// May 2025

LETI-101: Life Edit’s Novel Gene Editing Approach to Huntington’s Disease Treatment

By Amy Pooler, Ph.D., SVP, Research and Development of Life Edit

View Insight

// Apr 2025

ElevateBio’s Next-Generation Sequencing Core: Meeting the Challenges of Cost, Time and Data Quality with Expertise and Collaboration

By Adriana Geldart, Ph.D., Senior Director, Next-Generation Sequencing, ElevateBio

View Insight

// Apr 2025

Partner Case Study: Accelerating Gene Editing Manufacturing

By ElevateBio and Beam Therapeutics

View Insight

// Feb 2025

Accelerating Innovative Cell Therapy Development Through Phase-Appropriate Potency Control

By Deb Bhattacharya, Ph.D., and Cindy Riggins, Ph.D., ElevateBio

View Insight

// Sep 2024

Introducing ElevateBio’s Emerging Technology Lab

By Mercedes Segura, PhD, VP, Process Development, ElevateBio BaseCamp

View Insight

// Sep 2024

How Life Edit is using AI to expand the therapeutic boundaries of CRISPR

By Shaorong (Ron) Chong, Ph.D., VP of Technology Development, and Joel Parker, Ph.D., VP of Computational Biology, Life Edit Therapeutics

View Insight

// Aug 2024

The complexities of tomorrow’s cell therapies: The future is gene editing

By Mitch Finer, Ph.D., Co-Founder of ElevateBio, former Chief Executive Officer of Life Edit Therapeutics, and Current Strategic Advisor to ElevateBio and Life Edit

View Insight

// Jul 2024

The Future of Manufacturing and Medicine Rising in Pittsburgh’s Hazelwood Green

By Mario Miele, SVP, Facilities and Engineering, ElevateBio

View Insight

MENU